174 related articles for article (PubMed ID: 20480364)
21. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.
Jarvis GA; Vedros NA
Infect Immun; 1987 Jan; 55(1):174-80. PubMed ID: 3098684
[TBL] [Abstract][Full Text] [Related]
22. The mechanisms of activation of normal human serum complement by Escherichia coli strains with K1 surface antigen.
Bugla-Płoskońska G; Cisowska A; Karpińska K; Jankowski S; Doroszkiewicz W
Folia Microbiol (Praha); 2006; 51(6):627-32. PubMed ID: 17455802
[TBL] [Abstract][Full Text] [Related]
23. Role of YadA, Ail, and Lipopolysaccharide in Serum Resistance of Yersinia enterocolitica Serotype O:3.
Biedzka-Sarek M; Venho R; Skurnik M
Infect Immun; 2005 Apr; 73(4):2232-44. PubMed ID: 15784567
[TBL] [Abstract][Full Text] [Related]
24. Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum.
Tomás JM; Ciurana B; Benedí VJ; Juarez A
J Gen Microbiol; 1988 Apr; 134(4):1009-16. PubMed ID: 3053980
[TBL] [Abstract][Full Text] [Related]
25. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
Mittal KR; Ingram DG
Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
[TBL] [Abstract][Full Text] [Related]
26. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
Tesh VL; Duncan RL; Morrison DC
J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
[TBL] [Abstract][Full Text] [Related]
27. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.
Joiner KA; Goldman R; Schmetz M; Berger M; Hammer CH; Frank MM; Leive L
J Immunol; 1984 Jan; 132(1):369-75. PubMed ID: 6197449
[TBL] [Abstract][Full Text] [Related]
28. A New Tool for Complement Research:
Mutti M; Ramoni K; Nagy G; Nagy E; Szijártó V
Front Immunol; 2018; 9():2770. PubMed ID: 30564230
[TBL] [Abstract][Full Text] [Related]
29. Bactericidal and opsonizing effects of normal serum on mutant strains of Salmonella typhimurium.
Shaio MF; Rowland H
Infect Immun; 1985 Sep; 49(3):647-53. PubMed ID: 3897060
[TBL] [Abstract][Full Text] [Related]
30. Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria.
Clas F; Euteneuer B; Stemmer F; Loos M
Behring Inst Mitt; 1989 Jul; (84):236-54. PubMed ID: 2552981
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.
Schiller NL
Infect Immun; 1988 Mar; 56(3):632-9. PubMed ID: 3125110
[TBL] [Abstract][Full Text] [Related]
32. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella.
Schweinle JE; Ezekowitz RA; Tenner AJ; Kuhlman M; Joiner KA
J Clin Invest; 1989 Dec; 84(6):1821-9. PubMed ID: 2592561
[TBL] [Abstract][Full Text] [Related]
33. Serum sensitivity of Neisseria gonorrhoeae: the role of lipopolysaccharide.
Shafer WM; Joiner K; Guymon LF; Cohen MS; Sparling PF
J Infect Dis; 1984 Feb; 149(2):175-83. PubMed ID: 6421941
[TBL] [Abstract][Full Text] [Related]
34. [Bactericidal activity of normal human serum to gram-negative rods with sialic acid containing lipopolysaccharide].
Bugla G; Doroszkiewicz W; Gamian A; Korzeniowska-Kowal A
Med Dosw Mikrobiol; 2004; 56(3):255-61. PubMed ID: 15773502
[TBL] [Abstract][Full Text] [Related]
35. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
[TBL] [Abstract][Full Text] [Related]
36. Proteomic Analysis of Outer Membrane Proteins from Salmonella Enteritidis Strains with Different Sensitivity to Human Serum.
Dudek B; Krzyżewska E; Kapczyńska K; Rybka J; Pawlak A; Korzekwa K; Klausa E; Bugla-Płoskońska G
PLoS One; 2016; 11(10):e0164069. PubMed ID: 27695090
[TBL] [Abstract][Full Text] [Related]
37. Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica.
Wachter E; Brade V
Infect Immun; 1989 Jul; 57(7):1984-9. PubMed ID: 2731980
[TBL] [Abstract][Full Text] [Related]
38. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
39. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity.
Tomás JM; Benedí VJ; Ciurana B; Jofre J
Infect Immun; 1986 Oct; 54(1):85-9. PubMed ID: 3531020
[TBL] [Abstract][Full Text] [Related]
40. Swarming growth and resistance of Proteus penneri and Proteus vulgaris strains to normal human serum.
Kwil I; Kaźmierczak D; Różalski A
Adv Clin Exp Med; 2013; 22(2):165-75. PubMed ID: 23709372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
